NANOLEK has won the prestigious national award PRIORITY-PHARMA”.

The main national award in the field of import substitution and technology transfer “Priority” is awarded to providers that have shown the greatest success in import substitution. This year, a record number of applications for award was taken from companies engaged in various economic sectors.

The goal of the award is to promote active development of import substitution in Russia, strengthen prestige of domestic producers, upswing demand for Russian-made products and technologies.

During the festive award ceremony, Maxim Stetsyuk, CEO of NANOLEK, thanked the contest organizers for the high rating given to the company’s performance:

We have set up a local production facility in Russia to manufacture polio vaccines, but there is still a lot to be done as pharmaceutics is one of the most complex industries. I wish to thank the government of the Kirov region and the Ministry of Industry and Trade of Russia, which provide support in our discoveries.

I would like to add that we live in a huge country and I suggest that all of us, companies gathered here in this place, funnel motivation to our young people, and demonstrate them by personal examples that today we can make breakthrough discoveries, look for new drugs, and not just localize production plants in Russia.

We aspire to be competitive and we can boast of having a huge potential and such awards certainly motivate us for further excellence to create something new. Dear colleagues, I wish all of you good luck!”